These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38508929)

  • 1. Subolesin knockdown in tick cells provides insights into vaccine protective mechanisms.
    Artigas-Jerónimo S; Villar M; Estrada-Peña A; Alberdi P; de la Fuente J
    Vaccine; 2024 Apr; 42(11):2801-2809. PubMed ID: 38508929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tick vaccines and the transmission of tick-borne pathogens.
    de la Fuente J; Kocan KM; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogens.
    de la Fuente J; Moreno-Cid JA; Galindo RC; Almazan C; Kocan KM; Merino O; Perez de la Lastra JM; Estrada-Peña A; Blouin EF
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():172-8. PubMed ID: 24589118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subolesin/akirin orthologs from Ornithodoros spp. soft ticks: cloning, RNAi gene silencing and protective effect of the recombinant proteins.
    Manzano-Román R; Díaz-Martín V; Oleaga A; Siles-Lucas M; Pérez-Sánchez R
    Vet Parasitol; 2012 Apr; 185(2-4):248-59. PubMed ID: 22105082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen.
    Torina A; Moreno-Cid JA; Blanda V; Fernández de Mera IG; de la Lastra JM; Scimeca S; Blanda M; Scariano ME; Briganò S; Disclafani R; Piazza A; Vicente J; Gortázar C; Caracappa S; Lelli RC; de la Fuente J
    Parasit Vectors; 2014 Jan; 7():10. PubMed ID: 24398155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina.
    Merino O; Almazán C; Canales M; Villar M; Moreno-Cid JA; Galindo RC; de la Fuente J
    Vaccine; 2011 Nov; 29(47):8575-9. PubMed ID: 21951878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subolesin expression in response to pathogen infection in ticks.
    Zivkovic Z; Torina A; Mitra R; Alongi A; Scimeca S; Kocan KM; Galindo RC; Almazán C; Blouin EF; Villar M; Nijhof AM; Mani R; La Barbera G; Caracappa S; Jongejan F; de la Fuente J
    BMC Immunol; 2010 Feb; 11():7. PubMed ID: 20170494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservation and immunogenicity of the mosquito ortholog of the tick-protective antigen, subolesin.
    Canales M; Naranjo V; Almazán C; Molina R; Tsuruta SA; Szabó MP; Manzano-Roman R; Pérez de la Lastra JM; Kocan KM; Jiménez MI; Lucientes J; Villar M; de la Fuente J
    Parasitol Res; 2009 Jul; 105(1):97-111. PubMed ID: 19229557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
    Artigas-Jerónimo S; De La Fuente J; Villar M
    Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of Ixodes ricinus and Dermacentor reticulatus tick infestations in rabbits vaccinated with the Q38 Subolesin/Akirin chimera.
    Contreras M; de la Fuente J
    Vaccine; 2016 Jun; 34(27):3010-3013. PubMed ID: 27154388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subolesin vaccination inhibits blood feeding and reproduction of Haemaphysalis longicornis in rabbits.
    Lee SH; Li J; Moumouni PFA; Okado K; Zheng W; Liu M; Ji S; Kim S; Umemiya-Shirafuji R; Xuan X
    Parasit Vectors; 2020 Sep; 13(1):478. PubMed ID: 32948229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant subolesin does not reduce tick infection with tick-borne encephalitis virus nor protect mice against disease.
    Havlíková S; Ličková M; Ayllón N; Roller L; Kazimírová M; Slovák M; Moreno-Cid JA; Pérez de la Lastra JM; Klempa B; de la Fuente J
    Vaccine; 2013 Mar; 31(12):1582-9. PubMed ID: 23357197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission.
    de la Fuente J; Moreno-Cid JA; Canales M; Villar M; de la Lastra JM; Kocan KM; Galindo RC; Almazán C; Blouin EF
    Vet Parasitol; 2011 Sep; 181(1):17-22. PubMed ID: 21561715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tick Importin-α Is Implicated in the Interactome and Regulome of the Cofactor Subolesin.
    Artigas-Jerónimo S; Villar M; Cabezas-Cruz A; Caignard G; Vitour D; Richardson J; Lacour S; Attoui H; Bell-Sakyi L; Allain E; Nijhof AM; Militzer N; Pinecki Socias S; de la Fuente J
    Pathogens; 2021 Apr; 10(4):. PubMed ID: 33920361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of multiple arthropod vector infestations with subolesin/akirin vaccines.
    Moreno-Cid JA; Pérez de la Lastra JM; Villar M; Jiménez M; Pinal R; Estrada-Peña A; Molina R; Lucientes J; Gortázar C; de la Fuente J;
    Vaccine; 2013 Feb; 31(8):1187-96. PubMed ID: 23291476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Vaccination With a Formulation Combining
    Contreras M; Kasaija PD; Merino O; de la Cruz-Hernandez NI; Gortazar C; de la Fuente J
    Front Cell Infect Microbiol; 2019; 9():45. PubMed ID: 30881925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tick vaccines and the control of tick-borne pathogens.
    Merino O; Alberdi P; Pérez de la Lastra JM; de la Fuente J
    Front Cell Infect Microbiol; 2013; 3():30. PubMed ID: 23847771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.